Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2025 Earnings Call Transcript November 13, 2025
Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.40538, expectations were $-1.91.
Operator: Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences, Inc. Third Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call, you...
